BHVN logo

Biohaven Pharmaceutical Holding (BHVN) Working Capital

Annual Working Capital

$387.02 M
-$109.92 M-22.12%

31 December 2023

BHVN Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

$288.21 M
-$66.86 M-18.83%

30 September 2024

BHVN Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BHVN Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-22.1%+16.0%
3 y3 years+18.8%-15.7%
5 y5 years+53.1%+10.0%

BHVN Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-22.1%+18.8%-51.6%+453.0%
5 y5 years-22.1%+53.1%-51.6%+453.0%
alltimeall time-22.1%>+9999.0%-51.6%+1690.9%

Biohaven Pharmaceutical Holding Working Capital History

DateAnnualQuarterly
Sept 2024
-
$288.21 M(-18.8%)
June 2024
-
$355.06 M(+35.4%)
Mar 2024
-
$262.16 M(-32.3%)
Dec 2023
$387.02 M(-22.1%)
$387.02 M(+55.8%)
Sept 2023
-
$248.39 M(-28.3%)
June 2023
-
$346.27 M(-19.6%)
Mar 2023
-
$430.47 M(-13.4%)
Dec 2022
$496.95 M(+45.3%)
$496.95 M(+853.6%)
Sept 2022
-
$52.12 M(-89.6%)
June 2022
-
$502.38 M(-15.6%)
Mar 2022
-
$594.97 M(+73.9%)
Dec 2021
$342.05 M(+5.0%)
-
Dec 2021
-
$342.05 M(-29.1%)
Sept 2021
-
$482.11 M(+80.3%)
June 2021
-
$267.45 M(-47.0%)
Mar 2021
-
$504.90 M(+55.0%)
Dec 2020
$325.80 M
-
Dec 2020
-
$325.80 M(-33.7%)
Sept 2020
-
$491.17 M(+150.4%)
DateAnnualQuarterly
June 2020
-
$196.15 M(-44.3%)
Mar 2020
-
$352.35 M(+34.4%)
Dec 2019
$262.11 M(+3.7%)
-
Dec 2019
-
$262.11 M(-30.3%)
Sept 2019
-
$375.96 M(-12.5%)
June 2019
-
$429.68 M(+111.0%)
Mar 2019
-
$203.68 M(-19.4%)
Dec 2018
$252.81 M(+98.7%)
-
Dec 2018
-
$252.81 M(+50.7%)
Sept 2018
-
$167.72 M(-21.9%)
June 2018
-
$214.85 M(+119.7%)
Mar 2018
-
$97.81 M(-23.1%)
Dec 2017
$127.24 M(+690.6%)
-
Dec 2017
-
$127.24 M(-19.2%)
Sept 2017
-
$157.39 M(-17.6%)
June 2017
-
$191.09 M(+406.5%)
Mar 2017
-
$37.73 M(+134.4%)
Dec 2016
$16.09 M(+932.9%)
-
Dec 2016
-
$16.09 M
Dec 2015
$1.56 M
-

FAQ

  • What is Biohaven Pharmaceutical Holding annual working capital?
  • What is the all time high annual working capital for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding annual working capital year-on-year change?
  • What is Biohaven Pharmaceutical Holding quarterly working capital?
  • What is the all time high quarterly working capital for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding quarterly working capital year-on-year change?

What is Biohaven Pharmaceutical Holding annual working capital?

The current annual working capital of BHVN is $387.02 M

What is the all time high annual working capital for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high annual working capital is $496.95 M

What is Biohaven Pharmaceutical Holding annual working capital year-on-year change?

Over the past year, BHVN annual working capital has changed by -$109.92 M (-22.12%)

What is Biohaven Pharmaceutical Holding quarterly working capital?

The current quarterly working capital of BHVN is $288.21 M

What is the all time high quarterly working capital for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high quarterly working capital is $594.97 M

What is Biohaven Pharmaceutical Holding quarterly working capital year-on-year change?

Over the past year, BHVN quarterly working capital has changed by +$39.81 M (+16.03%)